AP Biosciences, Inc. engages in the research and development of new antibody drug and immunotherapy drugs. It focuses on the cancer immunotherapy bi-specific antibody drugs. The company was founded on May 27, 2013 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company